63 filings
8-K
CDXI
Cardax, Inc.
11 Aug 21
Cardax Voluntarily Suspends SEC Reporting Obligations
5:00pm
8-K
CDXI
Cardax, Inc.
1 Jul 21
Changes in Registrant's Certifying Accountant
8:00am
8-K
CDXI
Cardax, Inc.
13 Jan 21
Entry into a Material Definitive Agreement
4:59pm
8-K
CDXI
Cardax, Inc.
18 Nov 20
Regulation FD Disclosure
4:58pm
8-K
CDXI
Cardax, Inc.
15 May 20
Entry into a Material Definitive Agreement
4:01pm
8-K
chz68gajyfmt9 vdqb39
20 Mar 20
Entry into a Material Definitive Agreement
5:07pm
8-K
wrg kkq555nyb
27 Jan 20
Entry into a Material Definitive Agreement
5:08pm
8-K
etsa7wh
14 Jan 20
Cardax, Inc. Announces Reverse Stock Split of Common Stock
5:00pm
8-K
mt6xhbqa3ezh2r8
6 Dec 19
Regulation FD Disclosure
5:26pm
8-K
09a h9urh525f
8 Oct 19
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
xub99pb ohh0kxyx
23 Sep 19
Cardax Announces Interim Results from CHASE Clinical Trial
8:00am
8-K
w6toza7rjaibm
25 Jul 19
Entry into a Material Definitive Agreement
4:00pm
8-K
ap2ttn5slp0nhqaa0c6
25 Jan 19
Regulation FD Disclosure
8:00am
8-K
59cs aq58
6 Dec 18
Submission of Matters to a Vote of Security Holders
8:00am
8-K
bnes421cmbxbhd
2 Oct 18
Cardax Launches Human Clinical Trial Targeting Cardiovascular Inflammatory Health
8:00am
8-K
3adbil4s oxk8g
30 Jul 18
Cardax Announces Successful Completion of Warrant Exchange Offer
12:00am
8-K
kwchcvd0ht z4vikp
23 Jul 18
Regulation FD Disclosure
5:00pm
8-K
5xcfljdv768kwqcc9
22 Jun 18
Cardax Announces Effectiveness of Registration Statement and Commencement of Warrant Exchange Offer
1:45pm
8-K
47mdalq
13 Jun 18
Cardax Engages Industry Veteran Fred Sancilio, Ph.D. to Launch Orphan Drug Development Program
12:00am
8-K
4dfhk
1 Jun 18
Cardax Adds Makarand Jawadekar, Ph.D., and Elona Kogan to its Board of Directors
8:00am